216 related articles for article (PubMed ID: 11128359)
21. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.
Russo GT; Di Benedetto A; Magazzù D; Giandalia A; Giorda CB; Ientile R; Previti M; Di Cesare E; Cucinotta D
Acta Diabetol; 2011 Jun; 48(2):95-101. PubMed ID: 19937354
[TBL] [Abstract][Full Text] [Related]
22. Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus.
Agulló-Ortuño MT; Albaladejo MD; Parra S; Rodríguez-Manotas M; Fenollar M; Ruíz-Espejo F; Tebar J; Martínez P
Clin Chim Acta; 2002 Dec; 326(1-2):105-12. PubMed ID: 12417101
[TBL] [Abstract][Full Text] [Related]
23. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study.
Meigs JB; Jacques PF; Selhub J; Singer DE; Nathan DM; Rifai N; D'Agostino RB; Wilson PW;
Diabetes Care; 2001 Aug; 24(8):1403-10. PubMed ID: 11473077
[TBL] [Abstract][Full Text] [Related]
24. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Smulders YM; Rakic M; Slaats EH; Treskes M; Sijbrands EJ; Odekerken DA; Stehouwer CD; Silberbusch J
Diabetes Care; 1999 Jan; 22(1):125-32. PubMed ID: 10333913
[TBL] [Abstract][Full Text] [Related]
25. Total plasma homocysteine correlates in women with gestational diabetes.
Idzior-Waluś B; Cyganek K; Sztefko K; Seghieri G; Breschi MC; Waluś-Miarka M; Kawalec E; Seretny M; Sieradzki J
Arch Gynecol Obstet; 2008 Oct; 278(4):309-13. PubMed ID: 18236055
[TBL] [Abstract][Full Text] [Related]
26. Plasma Homocysteine is Associated with Retinopathy in Type 1 Diabetic Patients in the Absence of Nephropathy.
Bulum T; Blaslov K; Duvnjak L
Semin Ophthalmol; 2016; 31(3):198-202. PubMed ID: 24785685
[TBL] [Abstract][Full Text] [Related]
27. Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients.
Shimomura T; Anan F; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H; Fujiki M; Kobayashi H
Eur J Neurol; 2008 Mar; 15(3):289-94. PubMed ID: 18290850
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
29. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation.
Bosy-Westphal A; Ruschmeyer M; Czech N; Oehler G; Hinrichsen H; Plauth M; Lotterer E; Fleig W; Müller MJ
Am J Clin Nutr; 2003 May; 77(5):1269-77. PubMed ID: 12716682
[TBL] [Abstract][Full Text] [Related]
30. Reduced serum homocysteine levels in type 2 diabetes.
Mazza A; Bossone E; Mazza F; Distante A
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
[TBL] [Abstract][Full Text] [Related]
31. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
32. Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.
Tan KC; O K; Chow WS; Ai VH; Siow YL; Lam KS
Eur J Clin Invest; 2002 May; 32(5):328-34. PubMed ID: 12027872
[TBL] [Abstract][Full Text] [Related]
33. Effective treatment of hyperhomocysteinemia in heart transplant recipients with and without renal failure.
Cook RC; Parker S; Kingsbury K; Frohlich JJ; Abel JG; Gao M; Ignaszewski AP
J Heart Lung Transplant; 2001 Mar; 20(3):310-5. PubMed ID: 11257557
[TBL] [Abstract][Full Text] [Related]
34. [The impact of plasma homocysteine level on development of retinopathy in type 2 diabetes mellitus].
Yang G; Lu J; Pan C
Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):34-8. PubMed ID: 11940295
[TBL] [Abstract][Full Text] [Related]
35. Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran.
Monfared A; Azimi SZ; Kazemnezhad E; Khosravi M; Lebadi M; Mirzajani E; Ashtiani MN
Transplantation; 2014 Jul; 98(1):66-71. PubMed ID: 24978036
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.
Anan F; Yonemochi H; Masaki T; Takahashi N; Nakagawa M; Eshima N; Saikawa T; Yoshimatsu H
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):28-35. PubMed ID: 16896659
[TBL] [Abstract][Full Text] [Related]
37. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
39. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
[TBL] [Abstract][Full Text] [Related]
40. Mild hyperhomocysteinemia in adult patients with sickle cell disease: a common finding unrelated to folate and cobalamin status.
Dhar M; Bellevue R; Brar S; Carmel R
Am J Hematol; 2004 Jun; 76(2):114-20. PubMed ID: 15164375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
